Skip to main navigation
Skip to search
Skip to main content
University of Toyama Home
日本語
English
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Courses
Search by expertise, name or affiliation
Genetic modification of T cells for cancer therapy
C. Imai
, Dario Campana
*
*
Corresponding author for this work
Pediatrics
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Genetic modification of T cells for cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Therapy
100%
Immune Cells
100%
T Cells
100%
Genetic Modification
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Cancer Cells
50%
Clinical Research
25%
Clinical Trials
25%
Allogeneic
25%
Clinical Data
25%
Costimulatory Molecules
25%
Signaling Molecules
25%
Anticancer Activity
25%
Target Molecule
25%
Cancer Treatment
25%
CD28
25%
Cell Therapy
25%
4-1BB
25%
Long-term Persistence
25%
Variable Domains
25%
Murine Antibody
25%
Possible Complications
25%
Durable Immune Response
25%
Medicine and Dentistry
Receptor
100%
T Cell
100%
Cancer Therapy
100%
Immunocompetent Cell
100%
Cancer Cell
50%
In Vitro
25%
Clinical Trial
25%
Signaling Molecule
25%
Immune Response
25%
Antineoplastic Activity
25%
Cancer Treatment
25%
Cell Therapy
25%
Clinical Research
25%
Co-Stimulatory Molecule
25%
Biochemistry, Genetics and Molecular Biology
Immunocompetent Cell
100%
T Cell
100%
DNA Modification
100%
Cancer Cell
50%
Animal Model
25%
In Vitro Study
25%
Clinical Trial
25%
Antineoplastic Activity
25%
Immune Response
25%
CD28
25%
Clinical Research
25%
Immunology and Microbiology
Immunocompetent Cell
100%
T Cell
100%
DNA Modification
100%
Cancer Cell
50%
Immune Response
25%
Antineoplastic Activity
25%
CD28
25%
Co-Stimulatory Molecule
25%
Immunology
25%